SEDAJECT™ & ATAJECT™
Sedative - Analgesic and Reversing Agent for Companion Animals.
SEDAJECT™
(Dexmedetomidine hydrochloride injection, 0.5 mg/mL)
Veterinary Use Only
Sedative and analgesic
For IM or IV administration in dogs and cats
Indications:
- Sedative and analgesic in dogs and cats to facilitate clinical examinations, clinical procedures, minor surgical procedures, and minor dental procedures
- Also indicated for use as a preanesthetic to general anesthesia in dogs and cats
ATAJECT™
(Atipamezole hydrochloride injection, 5.0 mg/mL)
Veterinary Use Only
Dexmedetomidine and Medetomidine Reversing Agent
For IM administration in dogs
Indications:
- Indicated for the reversal of the clinical effects of the sedative and analgesic agents dexmedetomidine hydrochloride and medetomidine hydrochloride in dogs
SEDAJECT™ & ATAJECT™
SEDAJECT™ and ATAJECT™ were developed by Vetpharma Animal Health S.L. and are manufactured in Spain. Both products are sold in over ten countries in Europe including Spain, France and Belgium.
![Ataject_Sedaject injectables group shot](https://products.greywolfah.com/wp-content/uploads/2022/04/Ataject_Sedaject-New-Group-Shot_31Mar22_EN.png)
Grey Wolf Animal Health is proud to be the Canadian distributor of Vetpharma Animal Health S.L.